
Goefibro-M 25 Tablet
Marketer
Koye Pharmaceuticals Pvt ltd
Salt Composition
Mifepristone (25mg)
Overview Goefibro-M 25 Tablet
Mifegest 25mg tablets belong to the antiprogestin steroid drug class, indicated for medically induced abortion. Its mechanism involves progesterone receptor antagonism, a hormone crucial for pregnancy maintenance. Mifegest 25mg may be administered alone or with other medications for optimal efficacy. Take with food, or as directed by your physician. Swallow the tablets whole with water. Report vomiting within 45 minutes of ingestion to your doctor; a repeat dose may be necessary. The medication's effects, including bleeding, typically manifest within 24-48 hours. Common side effects encompass nausea, vomiting, uterine cramping, diarrhea, post-abortion infection, and uterine bleeding. Report persistent or severe side effects to your healthcare provider; management strategies are available. Seek immediate medical attention for heavy vaginal bleeding or abdominal pain. Prior to use, disclose any history of ectopic pregnancy, breastfeeding, or intrauterine device use. Inform your doctor of all concurrent medications, as interactions may reduce efficacy or alter the drug's action. Avoid strenuous activities such as heavy exercise, running, and driving during the abortion process due to potential bleeding complications. Your physician may conduct an ultrasound or pelvic exam to confirm the abortion's completion.
Uses of Goefibro-M 25 Tablet
Medication-induced termination of pregnancy
Major Benefits of Goefibro-M 25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goefibro-M 25 Tablet should be administered with a meal.
Common Side effects of Goefibro-M 25 Tablet:
- Nausea
- Vomiting
- Uterine cramps
- Diarrhea
- Infection following abortion
- Uterine bleeding
How to use Goefibro-M 25 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Goefibro-M 25 Tablet should be administered with a meal.
How Goefibro-M 25 Tablet works:
Goefibro-M 25 Tablet inhibits progesterone, a hormone crucial for pregnancy maintenance. Its action disrupts the uterine lining, mimicking menstruation and thus terminating pregnancy.
SAFETY ADVICE
AlcoholUNSAFE
Combining Goefibro-M 25 Tablet and alcohol is unsafe.
PregnancyUNSAFE
Using Goefibro-M 25 Tablet during pregnancy is strongly contraindicated. Pregnant women should consult their physician; research in animals and pregnant humans reveals substantial risks to the fetus.
Breast feedingCONSULT YOUR DOCTOR
The use of Goefibro-M 25 Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Goefibro-M 25 Tablet might cause drowsiness, blurred vision, and dizziness, reducing alertness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Data regarding Goefibro-M 25 Tablet use in patients exhibiting renal impairment is scarce. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding Goefibro-M 25 Tablet use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Goefibro-M 25 Tablet :
Should you forget to take a Goefibro-M 25 Tablet, seek advice from your physician.
Facts to Know About Goefibro-M 25 Tablet
| Label | Value |
|---|---|
| Chemical Type | Oxosteroid |
| Developing Habits | No. |
| Treatment Category | OBSTETRICS AND GYNECOLOGY |
| Action Class | Progesterone antagonist |
